<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-42 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-42</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-42</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-1.html">extraction-schema-1</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <p><strong>Paper ID:</strong> paper-272062010</p>
                <p><strong>Paper Title:</strong> <a href="https://jurnal.ugm.ac.id/v3/InaJBCS/article/download/15943/4834" target="_blank">EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer</a></p>
                <p><strong>Paper Abstract:</strong> Targeted therapies have shown promise in improving survival rates for lung adenocarcinoma, a common and deadly malignancy. EGFR -targeting tyrosine kinase inhibitors (TKIs) are particularly effective among these therapies in cases with EGFR mutations. Detecting these mutations before TKI treatment is essential. Various radiological features have been linked to EGFR mutations. However, the relationship between tumor location and mutation types in Indonesian lung adenocarcinoma patients remains unexplored. This study aimed to identify the frequency of EGFR mutation in local lung adenocarcinoma cases based on the tumor location. Clinical data of lung adenocarcinoma patients (n = 272) diagnosed between 2018 and 2022 were retrospectively taken from the Department of Anatomical Pathology, Dr. Sardjito General Hospital, Yogyakarta. The qRT-PCR data of EGFR mutation status was obtained from the</p>
                <p><strong>Cost:</strong> 0.014</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e42.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e42.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Indonesian Yogyakarta cohort</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer (Dr. Sardjito General Hospital, Yogyakarta)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Retrospective cohort of 272 Indonesian patients with lung adenocarcinoma (2018-2022) in which EGFR mutation testing by qRT-PCR was performed and mutation frequencies, subtypes, and associations with sex, age and tumor laterality were reported.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>272 Indonesian patients with lung adenocarcinoma diagnosed at Dr. Sardjito General Hospital, Yogyakarta (2018-2022)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Indonesian / Southeast Asian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>165/272 = 60.7%</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Exon 19 deletions: 96 cases (58.2% of EGFR-mutant group; 96/272 = 35.3% of total); Exon 21 L858R: 35 cases (21.2% of EGFR-mutant group; 35/272 = 12.9% of total); Uncommon mutations: 34 cases (20.6% of EGFR-mutant group; 34/272 = 12.5% of total). Exon 20 was not examined in detail in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Paper notes indoor cooking smoke exposure as a possible contributor to higher female adenocarcinoma prevalence in Asia (mentioned as background), but no direct exposure data for this cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>The paper contrasts its Indonesian frequency (60.7%) to broader literature reporting higher frequencies in Asian populations and lower frequencies in Caucasian populations (see separate entries); no direct multi-ethnic comparison within the study sample.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors discuss possible explanations in the literature: higher estrogen exposure in Asian women (hypothesized), correlation between estrogen receptor expression and EGFR mutations, age-related accumulation of somatic mutations, and possible racial variation in the proportional distribution of EGFR mutation subtypes; no germline loci or molecular mechanism tested in this cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>EGFR mutations were more frequent in females (66.7% of females had EGFR mutations) and in patients >50 years (64.0%); cohort composed predominantly of adenocarcinoma histology.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Limited molecular testing infrastructure in Indonesia noted as background; retrospective design; lack of smoking data; single-center regional sample may limit generalizability; exon 20 not fully examined.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Data represent a single center in Yogyakarta, Indonesia; authors call for broader geographic sampling to investigate regional variation within Indonesia and across Asia.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e42.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Asian (aggregate)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Across Asian populations (aggregate statement in paper)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Background statement in the paper summarizing published estimates of EGFR mutation prevalence in Asian patient populations with lung adenocarcinoma.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Aggregate / literature-derived Asian populations (no single study population given in-text)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>East Asian / Asian (aggregate)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported in paper as approximately 40-60% in lung adenocarcinoma across Asian populations.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Paper mentions indoor cooking smoke exposure in Asia as a possible background factor for sex differences, but not presented as a quantified contributor to ethnic differences here.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared in the paper to Caucasian populations (see separate entry) which are reported at much lower frequencies.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Paper discusses hypotheses in the literature such as hormonal (estrogen) differences and potential racial/ancestral differences in mutation subtype distributions as possible explanations, but no specific germline variants are provided.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>In aggregate, EGFR mutations are noted to be more common in Asian patients, often enriched in females and in adenocarcinoma histology (background statement).</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Heterogeneity of source studies, differences in testing methods and sampling, and geographic/center effects not detailed in the aggregate statement.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Statement is pan-Asian; authors and cited literature imply regional heterogeneity but no detailed breakdown here.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e42.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Caucasian (aggregate)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Caucasian populations (aggregate statement in paper)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Background statement providing an approximate prevalence of EGFR mutations in lung adenocarcinoma among Caucasian (European-descended) populations, used for contrast with Asian frequencies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Aggregate / literature-derived Caucasian populations (no single study population given in-text)</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Caucasian / European</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported in paper as approximately 12-15% in Caucasian populations with lung adenocarcinoma.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Directly compared in paper to Asian aggregate frequency (40-60% vs ~12-15%).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Paper mentions potential explanations in the literature (e.g., hormonal differences, racial variation in mutation subtype distribution) but does not present a tested mechanism for Caucasian populations.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Differences across studies, methodologies, and population ascertainment likely; not quantified in the paper.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Aggregate across Caucasian populations; no regional breakdown provided.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e42.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Tseng 2016 (Taiwan)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation and lobar location of lung adenocarcinoma (Tseng et al., 2016, Taiwan)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A Taiwan study cited that reported higher EGFR mutation prevalence in women with upper lobe adenocarcinoma and reported mutation frequencies stratified by sex and lobar location.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>EGFR mutation and lobar location of lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Not fully detailed in this paper; described in-text as a 2016 Taiwan study (Tseng et al.).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Taiwanese / East Asian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported in this paper as 71% EGFR mutation prevalence in women with upper-lobe adenocarcinoma versus 47% in men with lower-lobe adenocarcinoma (values reported in the paper's summary of Tseng et al.).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Paper reports that L858R (exon 21) had greater predominance in upper-lobe tumors relative to exon 19 deletions and wild-type in the Tseng study.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Comparison in original Tseng study was by lobar location and sex rather than by ethnicity; cited here as an Asian (Taiwan) data point compared qualitatively to other studies.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Tseng et al. observed spatial (lobar) differences and subtype (L858R) enrichment but did not provide a mechanistic explanation in the summary included in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Higher prevalence of EGFR mutations in women with upper-lobe tumors per the cited study.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Original study details not provided in this paper; statistical significance and control for confounders not fully discussed here.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Data specific to Taiwan (upper-lobe vs lower-lobe, sex-stratified).</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e42.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Shi 2017 (Sci Rep)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Radiological and clinical features associated with epidermal growth factor receptor mutation status of exon 19 and 21 in lung adenocarcinoma (Shi et al., 2017)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Study cited that assessed radiological/clinical features associated with common EGFR mutations (exon 19 and exon 21) and reported tendencies by tumor location though not always statistically significant.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Radiological and clinical features associated with epidermal growth factor receptor mutation status of exon 19 and 21 in lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Described in paper as 179 EGFR-mutant adenocarcinoma patients in the referenced study (exact overall population characterization not given in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Focus on common mutations: exon 19 deletions and L858R (exon 21); reported tendencies in lobar occurrence but not statistically significant per summary.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Referenced as another Asian study showing similar tendencies in lobar distribution of exon 19 vs 21 mutations but without statistical significance.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Study compared common EGFR mutations (exon 19 vs 21) to wild-type in relation to radiological features.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Paper notes that Shi et al. did not find statistically significant differences for lobar occurrence.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e42.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Isaka 2015 (Japan)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Correlations between the EGFR mutation status and clinicopathological features of clinical stage I lung adenocarcinoma (Isaka et al., 2015, Japan)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Japanese study cited that provided frequencies of exon 19 and exon 21 EGFR-mutated tumors by lung laterality among Japanese patients.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Correlations between the EGFR mutation status and clinicopathological features of clinical stage I lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Described in this paper as 212 Japanese lung adenocarcinoma patients (as cited).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Japanese / East Asian</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>In the cited summary the paper states exon 19: 53.4% and exon 21: 59.7% for EGFR-mutated tumors observed in the right lung (numbers reported in the paper's textual summary).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Authors reference Isaka's Japanese data to highlight differences in subtype proportions compared with their Indonesian cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>The paper suggests that differences in proportional distribution of mutation subtypes across studies/populations may reflect racial/ancestral variation, but Isaka study itself is cited mainly for observed frequencies.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Study population described as clinical stage I lung adenocarcinoma patients; further clinical details not reproduced here.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Original study statistical significance not detailed here; cited as observational comparison.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Specific to Japan; used to suggest inter-Asian differences in mutation subtype proportions.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e42.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Rizzo 2016 (Wisconsin, USA)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer (Rizzo et al., 2016)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>US study (Wisconsin) cited that included 280 patients and reported no difference between tumor location and EGFR mutation status.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Referenced as a Wisconsin, United States sample of 280 patients (per paper text).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Not specified in paper summary (likely US patient mix; cited here as non-Asian comparison).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Used as a non-Asian comparison showing no association between tumor laterality and EGFR mutation in that US cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Authors note consistency with Rizzo et al. in finding no laterality difference, while other Asian studies reported tendenciesâ€”differences could be due to population composition or subtype proportions.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>United States (Wisconsin) cohort; contrasted with Asian studies.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e42.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e42.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Midha mutMapII</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII) (Midha et al.)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A systematic review and global mapping study cited in the paper that examines EGFR mutation incidence by ethnicity worldwide.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Global / multiple ethnicities (systematic review by ethnicity)</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>This review underpins the paper's background statement comparing higher Asian vs lower Caucasian EGFR mutation frequencies.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Systematic-review level heterogeneity and differences in testing methodology across studies (implied by citation; not detailed here).</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Global map by ethnicity; used as a background source for ethnic frequency differences.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'EGFR mutation based on lung laterality in adenocarcinoma type of non-small cell lung cancer', 'publication_date_yy_mm': '2024-08'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII) <em>(Rating: 2)</em></li>
                <li>EGFR mutation and lobar location of lung adenocarcinoma <em>(Rating: 2)</em></li>
                <li>Radiological and clinical features associated with epidermal growth factor receptor mutation status of exon 19 and 21 in lung adenocarcinoma <em>(Rating: 2)</em></li>
                <li>Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients <em>(Rating: 2)</em></li>
                <li>Epidermal growth factor receptor somatic mutation analysis in 354 Chinese patients with non-small cell lung cancer <em>(Rating: 2)</em></li>
                <li>Distribution of EGFR mutations in 10,607 Russian patients with lung cancer <em>(Rating: 2)</em></li>
                <li>Correlations between the EGFR mutation status and clinicopathological features of clinical stage I lung adenocarcinoma <em>(Rating: 2)</em></li>
                <li>CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>